What is the best pre-operative risk stratification tool for major adverse cardiac events following elective vascular surgery? A prospective observational cohort study evaluating pre-operative myocardial ischaemia monitoring and biomarker analysis

Anaesthesia

Volumn 67, Issue 4, 2012, Pages 389-395

  Biccard, B M ^a   Naidoo, P ^b   De Vasconcellos, K ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; TROPONIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT CODING; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; VASCULAR SURGERY;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RISK ASSESSMENT; SOUTH AFRICA; SURGICAL PROCEDURES, ELECTIVE; TREATMENT OUTCOME; TROPONIN; VASCULAR SURGICAL PROCEDURES;

EID: 84858338690     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2011.07020.x     Document Type: Article

References (22)

1. Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH,. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. Canadian Medical Association Journal 2005; 173: 627-34. (Pubitemid 41345578)
2. Lee TH, Marcantonio ER, Mangione CM, et al., Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-9. (Pubitemid 29416229)
3. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM,. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. New England Journal of Medicine 1990; 323: 1781-8.
4. Choi JH, Cho DK, Song YB, et al., Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in noncardiac surgery. Heart 2010; 96: 56-62.
5. Fleisher LA, Beckman JA, Brown KA, et al., ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116: 1971-96.
6. Poldermans D, Bax JJ, Boersma E, et al., Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and European Society of Anaesthesiology (ESA). European Heart Journal 2009; 30: 2769-812.
7. Cook NR,. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clinical Chemistry 2008; 54: 17-23. (Pubitemid 351182592)
8. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS,. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statistics in Medicine 2008; 27: 157-72; discussion 207-12. (Pubitemid 351193639)
9. Biccard BM, Naidoo P,. The role of brain natriuretic peptide in prognostication and reclassification of risk in patients undergoing vascular surgery. Anaesthesia 2011; 66: 379-85.
10. Biccard BM, Lurati Buse GA, Burkhart C, et al., The influence of clinical risk factors on pre-operative B-type natriuretic peptide risk stratification of vascular surgical patients. Anaesthesia 2012; 67: 55-59.
11. Rodseth RN, Padayachee L, Biccard BM,. A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 2008; 63: 1226-33.
12. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR,. A simulation study of the number of events per variable in logistic regression analysis. Journal of Clinical Epidemiology 1996; 49: 1373-9. (Pubitemid 27028925)
13. Pencina MJ, D'Agostino RB Sr, Steyerberg EW,. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Statistics in Medicine 2011; 30: 11-21.
14. Rodseth RN, Lurati Buse GA, Bolliger D, et al., The predictive ability of pre-operative B-type natriuretic peptide in vascular patients for major adverse cardiac events an individual patient data meta-analysis. Journal of the American College of Cardiology 2011; 58: 522-9.
15. Ford MK, Beattie WS, Wijeysundera DN,. Systematic review: prediction of perioperative cardiac complications and mortality by the revised cardiac risk index. Annals of Internal Medicine 2010; 152: 26-35.
16. Biccard BM, Rodseth RN,. Utility of clinical risk predictors for preoperative cardiovascular risk prediction. British Journal of Anaesthesia 2011; 107: 133-43.
17. Ray P, Le Manach Y, Riou B, Houle TT,. Statistical evaluation of a biomarker. Anesthesiology 2010; 112: 1023-40.
18. Rodseth RN,. B type natriuretic peptide-a diagnostic breakthrough in peri-operative cardiac risk assessment? Anaesthesia 2009; 64: 165-78.
19. Struthers A, Lang C,. The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent 'pancardiac' target organ damage: BNP/N-BNP could become for the heart what microalbuminuria is for the kidney. European Heart Journal 2007; 28: 1678-82. (Pubitemid 47227107)
20. Biccard BM, Rodseth RN,. The pathophysiology of peri-operative myocardial infarction. Anaesthesia 2010; 65: 733-41.
21. Landesberg G,. Monitoring for myocardial ischemia. Best Practice and Research Clinical Anaesthesiology 2005; 19: 77-95. (Pubitemid 39646760)
22. Hlatky MA, Greenland P, Arnett DK, et al., Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009; 119: 2408-16.